The GLP-1 Forecast for 2024: Six Key Predictions

White Paper Obesity care and GLP-1s

Summary

According to leading indicators, consumer interest in GLP-1s shows no signs of abating in 2024. Strong demand will continue to spark innovation—as evidenced by the dozens of new formulations in the pipeline—yet cost and access will remain significant obstacles for employers and employees alike.

Download the White Paper

By submitting this form, I understand that Noom will process my personal information in accordance with their Privacy Policy.

Related Content

  • Blog
  • Obesity care and GLP-1s
  • May 1
  • 1 min read

Employer Strategies for Maximizing the Promise of GLP-1s

By Noom Team

  • Blog
  • Obesity care and GLP-1s
  • September 5
  • 1 min read

From Weight Loss to Risk: Understanding GLP-1’s Impact on Eating Disorders

By Jennifer Jones

  • Webinar
  • Obesity care and GLP-1s
  • May 10
  • 1 min read

Bridging the GLP-1 Care Gap for Better Outcomes and ROI

By Noom Team

Bring Noom to
your organization

Give your workforce a preview of what’s possible
for their physical and mental health.

REQUEST DEMO